HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Elefteriades, J. A. Articles by Geha, A. S. Search for Related Content PubMed PubMed Citation Articles by Elefteriades, J. A. Articles by Geha, A. S.

The Annals of Thoracic Surgery, Vol 49, 94-100, Copyright © 1990 by The Society of Thoracic Surgeons

ARTICLES

Evolving patterns in the surgical treatment of malignant ventricular tachyarrhythmias

JA Elefteriades, LA Biblo, WP Batsford, LE Rosenfeld, RW Henthorn, MD Carlson, AL Waldo, J Hsu and AS Geha
Section of Cardiothoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06510.

The advent of the automatic implantable cardioverter defibrillator (AICD), generally viewed as a safe and effective intervention, has in some measure discouraged the use of electrophysiologically directed endocardial resection for intractable ventricular arrhythmias. We reviewed the records of 127 patients undergoing either AICD procedures or resection over a 6-year period. Thirty-day mortality was 5.6% (5/89 patients) for all AICD procedures, 10.7% (3/28) for AICD placement plus coronary artery bypass grafting, and 11.8% (4/34) for resection. These mortality figures are not significantly different. Patients undergoing resection were less likely to require antiarrhythmic agents than patients given an AICD (33% versus 61%). Survival at 2 years was 78% in the resection group and 72% in the AICD group. Survival at 4 years was still 78% in the resection group. Only 1 late sudden death occurred in the AICD group and none in the resection group. We conclude that resection continues to be a valuable alternative, offering a greater overall benefit at only slightly increased risk.

This article has been cited by other articles:

				H. Rastegar, M. S. Link, C. B. Foote, P. J. Wang, A. S. Manolis, and N.A. M. Estes Perioperative and Long-term Results With Mapping-Guided Subendocardial Resection and Left Ventricular Endoaneurysmorrhaphy Circulation, September 1, 1996; 94(5): 1041 - 1048. [Abstract] [Full Text]

				D. M. Shahian, W. A. Williamson, F. J. Venditti Jr., D. T. Martin, and J. R. Ellis THE ROLE OF CORONARY REVASCULARIZATION IN RECIPIENTS OF AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1013 - 1022. [Abstract] [Full Text]